Publications (6)

Sort by: Date |
10 | 25 | 50 | 100 
Previous page Previous page1/1 Next page Last page
E H L P S All 
Small molecule designed to target metal binding site in the alpha 2I domain inhibits integrin function
(2007)
Journal of Medicinal Chemistry
Kapyla J, Pentikainen OT, Nyronen T, Nissinen L, Lassander S, Jokinen J, Lahti M, Marjamaki A, Johnson MS, Heino J,
Effects of conformational activation of integrin alpha 1I and alpha 2I domains on selective recognition of laminin and collagen subtypes. – Integrin alpha I domain activation
(2008)
Experimental Cell Research
Tulla M, Lahti M, Puranen JS, Brandt A, Kapyla J, Domogatskaya A, Salminen TA, Tryggvason K, Johnson MS, Heino J
Structure of Collagen Receptor Integrin alpha I-1 Domain Carrying the Activating Mutation E317A
(2011)
Journal of Biological Chemistry
Lahti M, Bligt E, Niskanen H, Parkash V, Brandt AM, Jokinen J, Patrikainen P, Kapyla J, Heino J, Salminen TA
Human parvoviruses B19, PARV4 and bocavirus in pediatric patients with allogeneic hematopoietic SCT
(2013)
Bone Marrow Transplantation
Rahiala J, Koskenvuo M, Norja P, Meriluoto M, Toppinen M, Lahtinen A, Väisänen E, Waris M, Vuorinen T, Saarinen-Pihkala U, Lappalainen M, Allander T, Ruuskanen O, Hedman K, Söderlund-Venermo M, Vettenranta K
Low cdc27 and high securin expression predict short survival for breast cancer patients
(2013)
APMIS
Talvinen K, Karra H, Pitkanen R, Ahonen I, Nykanen M, Lintunen M, Soderstrom M, Kuopio T, Kronqvist P
10 | 25 | 50 | 100 
Previous page Previous page1/1 Next page Last page
Share link